loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 7e77a68e D861 4aec 822a 4684ffdd1083 Applno 205422 Form Tablet Oral Dosage 0 25mg - Drug Product Composition: 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one

    Menu

    7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)-butoxy]-1H-quinolin-2-one

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 10,696Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 205422 / DOSAGE - TABLET;ORAL - 0.25MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    brexpiprazole(UNII: 2J3YBM1K8C)
    (brexpiprazole - UNII:2J3YBM1K8C)     		brexpiprazole1mg

    Inactive Ingredients

    Ingredient Name
    Avera McKennan Hospital
    FERRIC OXIDE YELLOW(EX438O2MRT)
    HYDROXYPROPYL CELLULOSE (1200000 MW)(RFW2ET671P)
    HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
    lactose monohydrate(EWQ57Q8I5X)
    LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED(2165RE0K14)
    magnesium stearate(70097M6I30)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
    starch, corn(O8232NY3SJ)
    talc(7SEV7J4R1U)
    TITANIUM DIOXIDE(15FIX9V2JP)